Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Merck KGaA’s relevant decision makers and contact details.
|Lead Date||Lead Type||Lead Description||Company Name||Drug Name||Therapy Area|
|05 Aug 2022||GDCTXXXX||Lorem||Lorem||Lorem||Cardiovascular|
|05 Aug 2022||Expected Trial Results||Phase II Results Expected in 2023||Merck KGaA||avelumab; cisplatin; trilaciclib||Immunology; Oncology; Toxicology|
|05 Aug 2022||Expected Trial Results||Phase II Results Expected in 2023||G1 Therapeutics Inc||avelumab; cisplatin; trilaciclib||Immunology; Oncology; Toxicology|
|21 Jul 2022||Expected Trial Completions||Phase I Trial Completion Expected on 28-Nov-2023||Merck KGaA||M-9140||Oncology|
Lead Sheet offers business development users in a Supplier Company, convenient access to leads within the biopharmaceutical industry.
- Lead: Any current or future events that signal a company may need services from another company in the near future.
Depending on the user’s company type, specific events may be considered a lead for the goods or services they provide.
Leads within Lead Sheet fall into six major types of occurrences: Trial Events, Regulatory Events, Deals, Insights, New Companies, and Role Changes.
Some of these categories are broken out further to allow users the flexibility to filter to the event types they consider a lead.
Any lead type starting with “Expected” implies that it is a future event sourced from our Catalyst Calendar.
Lead Sheet is a business development tool to help optimize sales efficiency
- What prospective accounts to target
- When and why to target them through actionable leads/opportunities
- Who to reach out to
Premium databases is part of our industry range of products
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer